SCHEMBL2919947

SCHEMBL2919947

O=C(O)Oc1cccnc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.53
LMNA P02545 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KMT2A Q03164 2/20 0.41
HSP90AA1 P07900 1/20 0.39
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
DHODH Q02127 1/20 0.38
GAA P10253 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5702580 0.80 KDM4E (0.50) NAPRTLMNAL3MBTL1METAP2METAP1
SCHEMBL27864719 0.79 NAPRT (0.43) NAPRTLMNAL3MBTL1KMT2AKDM4E
SCHEMBL377461 0.78 LMNA (0.42) NAPRTLMNAL3MBTL1METAP2METAP1
SCHEMBL16742738 0.78 L3MBTL1 (0.51) NAPRTL3MBTL1KDM4ETDP1ALDH1A1
SCHEMBL5178813 0.77 SMN1; SMN2 (0.53) LMNAL3MBTL1METAP2METAP1HDAC6
SCHEMBL10873387 0.77 LMNA (0.41) NAPRTLMNAL3MBTL1METAP2METAP1
SCHEMBL1836306 0.77 NAPRT (0.53) NAPRTLMNAL3MBTL1METAP2METAP1
SCHEMBL876096 0.77 SSTR4 (0.43) NAPRTLMNAL3MBTL1METAP2METAP1
SCHEMBL27784050 0.75 TSHR (0.41) NAPRTLMNAL3MBTL1HSP90AA1KDM4E
SCHEMBL3415803 0.74 LMNA (0.71) LMNAL3MBTL1METAP2METAP1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225227-B1 1',3'-Dihydrospiro[imidazolidin-4,2'-inden]-2,5-diones and 1,3-dihydrospiro[inden-2,3']-pyrroles as CGRP antagonists BOEHRINGER INGELHEIM INT (DE) 2015-08-26 EP disclosed
EP-2251339-A2 COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2010-11-17 EP disclosed
EP-2225227-A2 COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2010-09-08 EP disclosed
WO-2009065920-A2 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-28 WO disclosed